Andson Biotech
PrivateLast Round
Early Funding
Oct 30, 2025
Total Funding Raised
$9.25M
Momentum Score
50 /100
Company Overview
Andson Biotech is a biotechnology tools company that develops solutions to streamline and accelerate mass spectrometry workflows for the biopharmaceutical industry. Spun out of Georgia Institute of Technology, the company's flagship product is the DynaCHIP, a microfluidic-based hardware platform that integrates with existing mass spectrometers to significantly reduce sample preparation time from hours or days to minutes. This technology aims to democratize the use of mass spectrometry, a key analytical tool, for applications in drug discovery, development, and manufacturing quality control, particularly for advanced biotherapeutics like cell and gene therapies. The company is venture-backed, having participated in accelerators like Y Combinator and Merck Digital Sciences Studio, and has raised over $5 million in funding.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Drug Discovery, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Andson Biotech Comps
Public and private peers based on sector, stage, and business model.
Andson Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 30, 2025 | ||||
| Seed | Apr 30, 2024 | ||||
| Accelerator | Dec 15, 2022 | ||||
| Accelerator | Jan 10, 2022 | ||||
| Grant | Aug 20, 2020 |
Andson Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| McKesson Ventures | Accelerator |
| Merck Global Health Innovation Fund | Accelerator |
| Northpond Ventures | Accelerator |
| Y Combinator | Early Funding, Accelerator |
| Georgia Research Alliance | Grant |
| Biolocity | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors grew 110% MoM, reaching 2K.
- Oct 30, 2025
$5M raised in early funding.
Andson Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Andson Biotech's valuation, stock price, and market status.
